Disilver;bis(2-[(4-phenyltriazol-1-yl)methyl]pyridine);dinitrate
C28H24Ag2N10O6 — CID 139132081
Data last refreshed: (MolForge compound catalog, from PubChem)
About Disilver;bis(2-[(4-phenyltriazol-1-yl)methyl]pyridine);dinitrate
Disilver;bis(2-[(4-phenyltriazol-1-yl)methyl]pyridine);dinitrate (PubChem CID 139132081) has the molecular formula C28H24Ag2N10O6 and a molecular weight of 812.30 g/mol. Its IUPAC name is disilver;bis(2-[(4-phenyltriazol-1-yl)methyl]pyridine);dinitrate.
Molecular Properties
| Compound Name | Disilver;bis(2-[(4-phenyltriazol-1-yl)methyl]pyridine);dinitrate |
|---|---|
| PubChem CID | 139132081 |
| Molecular Formula | C28H24Ag2N10O6 |
| Molecular Weight | 812.30 g/mol |
| Exact Mass | 810.00 |
| IUPAC Name | disilver;bis(2-[(4-phenyltriazol-1-yl)methyl]pyridine);dinitrate |
| SMILES | O=[N+]([O-])[O-].O=[N+]([O-])[O-].[Ag+].[Ag+].c1ccc(-c2cn(Cc3ccccn3)nn2)cc1.c1ccc(-c2cn(Cc3ccccn3)nn2)cc1 |
| InChI | InChI=1S/2C14H12N4.2Ag.2NO3/c2*1-2-6-12(7-3-1)14-11-18(17-16-14)10-13-8-4-5-9-15-13;;;2*2-1(3)4/h2*1-9,11H,10H2;;;;/q;;2*+1;2*-1 |
| InChIKey | HBSODYRXFQVXPN-UHFFFAOYSA-N |
| XLogP | 4.29 |
| TPSA | 219.60 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 14 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 46 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 812.30 |
| LogP ≤ 5 | 4.29 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 14 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'nitro_group', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 139132081 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.